Your browser doesn't support javascript.
loading
Genomic Heterogeneity Underlies Mixed Response to Tropomyosin Receptor Kinase Inhibition in Recurrent Glioma.
Schram, A M; Jonsson, P; Drilon, A; Bale, T A; Hechtman, J F; Benayed, R; Hanusch, B; Young, R J; Grommes, C; Ku, N; Kaley, T; Hyman, D M; Taylor, B S.
Afiliação
  • Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Jonsson P; Weill Cornell Medical College, New York, NY.
  • Drilon A; These authors contributed equally to this work.
  • Bale TA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hechtman JF; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Benayed R; These authors contributed equally to this work.
  • Hanusch B; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Young RJ; Weill Cornell Medical College, New York, NY.
  • Grommes C; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ku N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Kaley T; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hyman DM; Clinical Research Administration, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Taylor BS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
JCO Precis Oncol ; 22018.
Article em En | MEDLINE | ID: mdl-31218270
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article